Membership Directory

Satori Pharmaceuticals Incorporated

Category: Drug Development
Phone: +1 (617) 547-0022
Fax: +1 (617) 482-3337
Website: http://www.satoripharma.com
Location: Cambridge, MA

Satori Pharmaceuticals Inc. (www.satoripharma.com) is a neuroscience company focused on the discovery and development of innovative disease-modifying therapies for Alzheimer?s disease, Parkinson?s disease and other neurodegenerative disorders. Satori is built on a strong foundation of innovative technology with a team of experienced pharmaceutical R&D drug discoverers and funding from leading venture capital firms.

Satori was founded in 2005 by Dr. Mark Findeis, PureTech Ventures and a group of world renowned neurodegenerative disease experts and experienced drug discoverers, including Dennis Selkoe, M.D., the Vincent and Stella Coates Professor of Neurologic Diseases at the Brigham and Women's Hospital, an affiliate of Harvard Medical School; Donald Price, M.D., Professor of Pathology, Neurology, and Neuroscience and Vice Chair for Research in the Department of Pathology and Director of the Division of Neuropathology at The Johns Hopkins University School of Medicine; Christopher Eckman, Ph.D., Associate Professor of Molecular Neuroscience, The Mayo Clinic, Jacksonville, FL; Jon Clardy, Ph.D., Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School; Jonathan King, Ph.D., Professor of Biology at Massachusetts Institute of Technology; Marlene Cohen, Ph.D., former Research Fellow at Eli Lilly & Company; and Tom Salzmann, Ph.D., former Executive Vice President, Merck Research Labs and board member of Sirtris Pharmaceuticals and Concert Pharmaceuticals.